>"In South Africa, a network of researchers are studying whether new lineages BA.4 and BA.5 escape immunity from COVID-19 vaccines and prior infections."
>"In South Africa, a network of researchers are studying whether new lineages BA.4 and BA.5 escape immunity from COVID-19 vaccines and prior infections."
"Ah, ivermectin. Before the pandemic, if you’d asked whether I was going to be spending much of my life writing about a drug mostly used to control endemic parasitic disease in Africa, I would’ve just…"
"Ah, ivermectin. Before the pandemic, if you’d asked whether I was going to be spending much of my life writing about a drug mostly used to control endemic parasitic disease in Africa, I would’ve just…"
The 95-year-old British monarch was “experiencing mild coldlike symptoms,” Buckingham Palace said. She recently met with her son Prince Charles, who had tested positive this _...Read More_
The 95-year-old British monarch was “experiencing mild coldlike symptoms,” Buckingham Palace said. She recently met with her son Prince Charles, who had tested positive this _...Read More_
Even the Queen has COVID — Just goes to show you that COVID doesn’t care who you are.
Wishing the Queen a quick recovery, and hoping that this converts some COVID deniers into believing that COVID is real.
Even the Queen has COVID — Just goes to show you that COVID doesn’t care who you are.
Wishing the Queen a quick recovery, and hoping that this converts some COVID deniers into believing that COVID is real.
"Booster shots of the Pfizer-BioNTech and Moderna vaccines lose substantial effectiveness after about four months — but still provided significant protection in keeping people out of the hospital during the omicron surge, according to a _...Read More_
"Booster shots of the Pfizer-BioNTech and Moderna vaccines lose substantial effectiveness after about four months — but still provided significant protection in keeping people out of the hospital during the omicron surge, according to a _...Read More_
"Pfizer and BioNTech in mid-December announced that two doses of the vaccine, given at a tenth of the amount of an adult dosing, did not produce a strong enough immune response in children ages 2 to 4."
"Pfizer and BioNTech in mid-December announced that two doses of the vaccine, given at a tenth of the amount of an adult dosing, did not produce a strong enough immune response in children ages 2 to 4."